Tag Archives: cost effectiveness

NHS Health Checks: value for money?

Reports in the Guardian and Telegraph this week report on a study published in the Journal of Public Health suggesting that the NHS health checks are costing £450,000 per life saved and therefore represent very poor value for money. Unfortunately these press reports are woefully misleading, although the study itself does little to discourage such …read more

Posted in Blog | Also tagged , | Comments closed

Is an intensive treatment regimen for newly diagnosed type 2 diabetes patients cost-effective? Economic evaluation of the 5-year results of the ADDITION study.

A new paper in Diabetic Medicine reports an economic evaluation of the ADDITION study, based on the five year follow-up data.  The Anglo-Danish-Dutch study of Intensive Treatment In peOple with screeN detected diabetes (ADDITION) is a prospective randomised controlled trial of screening and intensive treatment of newly diagnosed type-2 diabetes patients. The five-year outcomes, published …read more

Posted in Blog | Also tagged , , , | Group: | Comments closed

The economics won’t go away: NHS Cancer Drugs Fund to consider cost-effectiveness

This week, NHS England published its revised process for operation of the cancer drugs fund.  Of particular interest is the requirement to take into account both costs and effects of treatments. NICE was set up in 1999 with the remit of considering the value for money, or cost-effectiveness of new and existing treatments. It is …read more

Posted in Blog | Also tagged , , | Comments closed
  • The Cambridge Centre for Health Services Research (CCHSR) is a thriving collaboration between the University of Cambridge and RAND Europe. We aim to inform health policy and practice by conducting research and evaluation studies of organisation and delivery of healthcare, including safety, effectiveness, efficiency and patient experience.